Cite Filings / SPRY / 0001193125-23-130534

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ARS Pharmaceuticals, Inc. Filed 2023-05-01 Acc 0001193125-23-130534

Documents 1

DEF 14A Proxy Statement , d488212ddef14a.htm

Around this filing

2024-04-26 DEF 14A Proxy Statement
2023-05-03 EFFECT Notice of Effectiveness
2023-05-01 CORRESP Correspondence Between Filers and SEC Staff
2023-05-01 ARS Annual Report to Security Holders
2023-05-01 DEFA14A Proxy Materials
2023-05-01 DEF 14A Proxy Statement
2022-04-28 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d488212ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…